Baxter Bros’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCT
Baxter Bros's NVCT Position: Q3 2025 in Review
Baxter Bros sold out of Nuvectis Pharma (NVCT) in Q3 2025, closing a stake of 15,000 shares — an estimated $112K sold.
Baxter Bros first reported a position in NVCT in Q2 2024 and held it in 5 quarters. The position peaked at $147K in Q1 2025. 53 funds tracked by Wall St. Rank hold NVCT as of Q3 2025.
- Baxter Bros reported no remaining Nuvectis Pharma position as of Q3 2025 after selling out during the quarter.
- Baxter Bros sold 15,000 Nuvectis Pharma shares in Q3 2025, an estimated $112K.
- Baxter Bros first reported a position in Nuvectis Pharma in Q2 2024 and held it in 5 quarters.
- Baxter Bros's Nuvectis Pharma position peaked at $147K in Q1 2025.
- 53 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2025.
Based on Baxter Bros's 13F filing for Q3 2025, filed 14 Oct 2025.